Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rapid differential diagnosis of the B.1.617.2 (delta) variant of SARS-CoV-2 using an automated Cas12a-microfluidic system.

Chemical communications (Cambridge, England) - 19 Nov 2021

Li Pintao, Zhang Jin, Lin Qiuyuan, Kong Jilie, Fang Xueen

Abstract excerpt

An automated Cas12a-microfluidic system was constructed to distinguish the B.1.617.2 (delta) variant of SARS-CoV-2 from the wild-type virus rapidly and was validated using 30 clinical samples, showing 100% consistency with next-generation sequencing. It will be a potential tool for the rapid differential diagnosis of the delta variant of SARS-CoV-2.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Automation
Share to COVID-19
Share to CRISPR-Cas Systems

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Microfluidics

Share to Polymerase Chain Reaction

Share to RNA, Viral

Share to SARS-CoV-2

Source

Identifiers

PMID: 34751285
DOI: 10.1039/d1cc04874k

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rapid differential diagnosis of the B.1.617.2 (delta) variant of SARS-CoV-2 using an automated Cas12a-microfluidic system.PMID 34751285Read ↗

Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and SARS-CoV-2 variantsSemantic proximity Read ↗

High-Throughput and Integrated CRISPR/Cas12a-Based Molecular Diagnosis Using a Deep Learning Enabled Microfluidic System.Semantic proximity Read ↗

Detection and identification of SARS-CoV-2 and influenza a based on microfluidic technologySemantic proximity Read ↗

Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variantsSemantic proximity Read ↗

Rapid and accurate detection of SARS-CoV-2 mutations using a Cas12a-based sensing platform.Semantic proximity Read ↗

Integrated microfluidic system for the identification and multiple subtyping of influenza viruses by using a molecular diagnostic approachSemantic proximity Read ↗

Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants.Semantic proximity Read ↗

Rapid SARS-CoV-2 Variants Enzymatic Detection (SAVED) by CRISPR-Cas12aSemantic proximity Read ↗

Sensitive and Rapid Diagnosis of Respiratory Virus Coinfection Using a Microfluidic Chip‐Powered CRISPR/Cas12a SystemSemantic proximity Read ↗

An Artificial Intelligence Nanopore Platform Detects Omicron SARS-CoV-2 in Clinical SamplesSemantic proximity Read ↗

Centrifugal microfluidic-based multiplex recombinase polymerase amplification assay for rapid detection of SARS-CoV-2Semantic proximity Read ↗

Development of a Novel Multiplex PCR Method for the Rapid Detection of SARS-CoV-2, Influenza A Virus, and Influenza B VirusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.